MedWatch

Layoffs alleviate Ambu's need for more capital

A new cost-cutting plan means that the company is no longer on the hunt for new investors or other ways of raising capital.

CEO Britt Meelby Jensen | Photo: Atos / PR

Ambu is cutting DKK 250m (USD 34m) from its annual costs, and this will help to ensure that the Danish medtech firm will not need to raise new capital to keep the gears turning, says CEO Britt Meelby Jensen.

She and CFO Thomas Frederik Schmidt explained the new cuts in an investor teleconference after a guidance downgrade and the new savings plan were revealed alongside Ambu’s key figures from April, May and June.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs